
Neumora Therapeutics, Inc. Common Stock
NMRAHealthcare|Biotechnology|US
$0.50
+0.02 (+3.35%)
DCF Value
$1.10
Tangible Book / Share
$0.24
Cash / Share
$0.63
Next Earnings Report
Mar 10, 2027
EPS est. -$0.17
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 14, 2026 · GlobeNewsWire
SEC Filings (54)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 30, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Jul 27, 2026 | 8-K | Material event | DocumentIndex |
| Jun 15, 2026 | 8-K | Material event | DocumentIndex |
| May 29, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| May 4, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 17, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 17, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 1, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 30, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 30, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 30, 2026 | 8-K | Material event | DocumentIndex |
| Feb 19, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 11, 2026 | 8-K | Material event | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 21, 2025 | 8-K | Material event | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Oct 29, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 27, 2025 | 8-K | Material event | DocumentIndex |
| Oct 27, 2025 | 8-K | Material event | DocumentIndex |
| Aug 11, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2025 | 8-K | Material event | DocumentIndex |
| May 30, 2025 | 8-K | Material event | DocumentIndex |
| May 16, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 16, 2025 | 8-K | Material event | DocumentIndex |
| May 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2025 | 8-K | Material event | DocumentIndex |
| May 12, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 29, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 11, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 26, 2025 | EFFECT | DocumentIndex |